This announcement is a separate document:
北京市金杜（青岛）律师事务所关于海利尔药业集团股份有限公司2021年限制性股票激励计划首次授予部分第三期解除限售事宜的法律意见书
Legal opinion from Beijing Jindu (Qingdao) Law Firm on the lifting of sales restrictions in the third phase of the 2021 Restricted Stock Incentive Plan granted for the first time by Hailier Pharmaceutical Group Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.